N-(2-(7-Benzyl-4-imino-5,6-diphenyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)ethyl)pyridin-4-amine

ID: ALA5208351

PubChem CID: 50985828

Max Phase: Preclinical

Molecular Formula: C32H28N6

Molecular Weight: 496.62

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccccc3)c2ncn1CCNc1ccncc1

Standard InChI:  InChI=1S/C32H28N6/c33-31-29-28(25-12-6-2-7-13-25)30(26-14-8-3-9-15-26)38(22-24-10-4-1-5-11-24)32(29)36-23-37(31)21-20-35-27-16-18-34-19-17-27/h1-19,23,33H,20-22H2,(H,34,35)

Standard InChI Key:  HYEIDZYLIOTLFQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   -1.8714    0.5976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1569    1.0101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4425    0.5976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4425   -0.2276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2721   -0.6402    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9868   -0.2276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7715   -0.4826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9851   -1.2795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4017   -1.8628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6015   -1.6484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0218   -2.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2357   -3.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0329   -3.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6150   -2.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2567    0.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0817    0.1849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4959   -0.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3205   -0.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7296    0.1839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3169    0.8985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4944    0.8985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7716    0.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9852    1.6494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7855    1.8639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9943    2.6616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4126    3.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6155    3.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4019    2.2330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9868    0.5976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2721    1.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2721    1.8352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5859    1.0101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3004    0.5976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3004   -0.2274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0133   -0.6380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7296   -0.2254    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7296    0.5954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0179    1.0119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14  9  2  0
 15  7  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  2  0
 22 15  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 23  2  0
 29 22  1  0
  6 29  2  0
 29 30  1  0
  3 30  1  0
 30 31  2  0
  1 32  1  0
 32 33  1  0
 34 33  2  0
 35 34  1  0
 36 35  2  0
 37 36  1  0
 38 37  2  0
 33 38  1  0
M  END

Associated Targets(Human)

PC-3M (435 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 496.62Molecular Weight (Monoisotopic): 496.2375AlogP: 6.21#Rotatable Bonds: 8
Polar Surface Area: 71.52Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.96CX LogP: 5.50CX LogD: 3.63
Aromatic Rings: 6Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.96

References

1. Frankowski KJ, Patnaik S, Wang C, Southall N, Dutta D, De S, Li D, Dextras C, Lin YH, Bryant-Connah M, Davis D, Wang F, Wachsmuth LM, Shah P, Williams J, Kabir M, Zhu E, Baljinnyam B, Wang A, Xu X, Norton J, Ferrer M, Titus S, Simeonov A, Zheng W, Mathews Griner LA, Jadhav A, Aubé J, Henderson MJ, Rudloff U, Schoenen FJ, Huang S, Marugan JJ..  (2022)  Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.,  65  (12.0): [PMID:35696646] [10.1021/acs.jmedchem.2c00204]

Source